Investigating treatment effects on cartilage lesions during hallux valgus surgery
Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions
NA · Algemeen Ziekenhuis Maria Middelares · NCT04716140
This study is testing if treating cartilage damage during surgery for bunions helps patients feel better after their operation compared to those who don’t get the treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 99 (estimated) |
| Ages | 30 Years to 60 Years |
| Sex | All |
| Sponsor | Algemeen Ziekenhuis Maria Middelares (other) |
| Locations | 1 site (Ghent) |
| Trial ID | NCT04716140 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of treating cartilage lesions at the first metatarsophalangeal joint during corrective surgery for hallux valgus. It involves a randomized approach where patients are divided into two groups: one group will not receive treatment for cartilage lesions, while the other group will have their lesions treated through debridement and microfracture. The severity of cartilage lesions will be assessed using the ICRS scale and MS Hololens technology. Participants will complete questionnaires to assess their clinical outcomes pre- and post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 30 to 60 years who are scheduled for hallux valgus surgery.
Not a fit: Patients with additional pathologies other than hallux valgus or those outside the age range may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the optimal management of cartilage lesions during hallux valgus surgery, potentially improving patient outcomes.
How similar studies have performed: While there is limited literature on this specific approach, the study aims to fill a gap in understanding the treatment of cartilage lesions in this context, indicating a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * hallux valgus Exclusion Criteria: * younger than 30 years, older than 60 years * extra pathologies other than hallux valgus
Where this trial is running
Ghent
- AZ Maria Middelares — Ghent, Belgium (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hallux Valgus, Cartilage Damage